HomeCompareCANO vs JNJ

CANO vs JNJ: Dividend Comparison 2026

CANO yields 86.96% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CANO wins by $8.2K in total portfolio value
10 years
CANO
CANO
● Live price
86.96%
Share price
$2.30
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.7K
Annual income
$16.69
Full CANO calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CANO vs JNJ

📍 CANO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCANOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CANO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CANO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CANO
Annual income on $10K today (after 15% tax)
$7,391.30/yr
After 10yr DRIP, annual income (after tax)
$14.19/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $4,023.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CANO + JNJ for your $10,000?

CANO: 50%JNJ: 50%
100% JNJ50/50100% CANO
Portfolio after 10yr
$34.6K
Annual income
$2,383.29/yr
Blended yield
6.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CANO
Analyst Ratings
8
Hold
2
Sell
Consensus: Hold
Price Target
$402.33
+17392.6% upside vs current
Range: $125.00 — $832.00
Altman Z
-0.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CANO buys
0
JNJ buys
0
No recent congressional trades found for CANO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCANOJNJ
Forward yield86.96%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$38.7K$30.5K
Annual income after 10y$16.69$4,749.88
Total dividends collected$11.2K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$402.33$228.73

Year-by-year: CANO vs JNJ ($10,000, DRIP)

YearCANO PortfolioCANO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,048$4,347.83$10,594$274.49+$4.5KCANO
2$19,158$3,057.26$11,294$360.69+$7.9KCANO
3$22,318$1,818.88$12,133$476.91+$10.2KCANO
4$24,871$990.13$13,156$635.42+$11.7KCANO
5$27,127$515.59$14,432$854.61+$12.7KCANO
6$29,289$262.79$16,056$1,162.76+$13.2KCANO
7$31,472$132.59$18,175$1,604.53+$13.3KCANO
8$33,742$66.57$21,009$2,252.68+$12.7KCANO
9$36,137$33.35$24,911$3,229.73+$11.2KCANO
10$38,683$16.69$30,458$4,749.88+$8.2KCANO

CANO vs JNJ: Complete Analysis 2026

CANOStock

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. As of December 31, 2021, it operated 130 owned medical centers and approximately 1000 affiliate providers serving approximately 227,005 members. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

Full CANO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CANO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CANO vs SCHDCANO vs JEPICANO vs OCANO vs KOCANO vs MAINCANO vs ABBVCANO vs MRKCANO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.